Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Pignon

Showing results (31-40 of 144) with videos related to

Pageof 15
Sort By:
Plos One|March 10, 2016
Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case StudyBéranger Lueza, Audrey Mauguen, Jean-Pierre Pignon, et al.
Current Opinion in Oncology|April 7, 2007
Individual patients' data meta-analyses in head and neck cancerJean Bourhis, Aurélie Le Maître, Bertrand Baujat, et al.
Computational and Mathematical Methods in Medicine|March 24, 2018
Evaluation of Treatment Effect with Paired Failure Times in a Single-Arm Phase II Trial in OncologyMatthieu Texier, Federico Rotolo, Michel Ducreux, et al.
International Journal of Technology Assessment in Health Care|March 2, 2005
Meta-analysis when only the median survival times are known: a comparison with individual patient data resultsStefan Michiels, Pascal Piedbois, Sarah Burdett, et al.
Hematology/Oncology Clinics of North America|November 17, 2015
Chemotherapy for Nasopharyngeal Carcinoma - Current Recommendation and ControversiesHenry Sze, Pierre Blanchard, Wai Tong Ng, et al.
The New England Journal of Medicine|January 23, 2004
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancerRodrigo Arriagada, Bengt Bergman, Ariane Dunant, et al.
Journal of Clinical Epidemiology|February 19, 2011
Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancerPierre Blanchard, Catherine Hill, Chantal Guihenneuc-Jouyaux, et al.
Plos One|November 1, 2021
A frequentist one-step model for a simple network meta-analysis of time-to-event data in presence of an effect modifierMatthieu Faron, Pierre Blanchard, Laureen Ribassin-Majed, et al.
Current Opinion in Oncology|April 8, 2004
Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitationsJean Bourhis, Atoussa Etessami, Pierre Wilbault, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 21, 2011
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour sitePierre Blanchard, Bertrand Baujat, Victoria Holostenco, et al.
Pageof 15

Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
Plos One|March 10, 2016
Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case StudyBéranger Lueza, Audrey Mauguen, Jean-Pierre Pignon, et al.
Current Opinion in Oncology|April 7, 2007
Individual patients' data meta-analyses in head and neck cancerJean Bourhis, Aurélie Le Maître, Bertrand Baujat, et al.
Computational and Mathematical Methods in Medicine|March 24, 2018
Evaluation of Treatment Effect with Paired Failure Times in a Single-Arm Phase II Trial in OncologyMatthieu Texier, Federico Rotolo, Michel Ducreux, et al.
International Journal of Technology Assessment in Health Care|March 2, 2005
Meta-analysis when only the median survival times are known: a comparison with individual patient data resultsStefan Michiels, Pascal Piedbois, Sarah Burdett, et al.
Hematology/Oncology Clinics of North America|November 17, 2015
Chemotherapy for Nasopharyngeal Carcinoma - Current Recommendation and ControversiesHenry Sze, Pierre Blanchard, Wai Tong Ng, et al.
The New England Journal of Medicine|January 23, 2004
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancerRodrigo Arriagada, Bengt Bergman, Ariane Dunant, et al.
Journal of Clinical Epidemiology|February 19, 2011
Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancerPierre Blanchard, Catherine Hill, Chantal Guihenneuc-Jouyaux, et al.
Plos One|November 1, 2021
A frequentist one-step model for a simple network meta-analysis of time-to-event data in presence of an effect modifierMatthieu Faron, Pierre Blanchard, Laureen Ribassin-Majed, et al.
Current Opinion in Oncology|April 8, 2004
Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitationsJean Bourhis, Atoussa Etessami, Pierre Wilbault, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 21, 2011
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour sitePierre Blanchard, Bertrand Baujat, Victoria Holostenco, et al.
Pageof 15